http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
Labrador Gold Intersects 0.87g/t Au Over 55.9 Metres at New HM Occurrence Includes 38.37g/t Au Over 0.8 Meters
-
Standard BioTools (LAB) Announces Preliminary Fourth Quarter and Full Year 2023 Revenue
-
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue
-
Standard BioTools (LAB) Completes Merger with SomaLogic (SLGC)
-
Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools
-
Standard BioTools Stockholders Approve Merger with SomaLogic
-
Glass Lewis Recommends Standard BioTools (LAB) Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic (SLGC)
-
Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
-
ISS Recommends Standard BioTools (LAB) Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic (SLGC)
-
ISS Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
-
Somalogic (SLGC) Issues Letter to Stockholders
-
SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools
-
Standard BioTools and SomaLogic Announce Date for Special Meetings of Stockholders to Vote on Proposed Merger
-
Labrador Gold Exercises Option to Acquire 100% of the Hopedale Property
-
Standard BioTools Reports Third Quarter and Year-to-Date 2023 Financial Results
-
Standard BioTools to Present at the Jefferies London Healthcare Conference
-
Standard BioTools Announces Conference Call and Webcast of Third Quarter 2023 Financial Results on November 7, 2023
-
Labrador Gold Receives Permits to Drill Targets in the Gap and Kingsway South
-
Standard BioTools (LAB) and SomaLogic (SLGC) to Combine in All-Stock Merger
-
Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools
-
Labrador Gold Reports High Grade Gold Assays Up to 30.58g/t Au Between Big Vein and Golden Glove
-
Labrador Gold Intersects 11.98g/t Au Over 6 Metres Including 30.61g/t Over 2.33 Metres in Follow Up Drilling at Pristine
-
Standard BioTools Reports Second Quarter 2023 Financial Results
-
Standard BioTools to Participate in Upcoming Investor Conferences
-
Standard BioTools Announces Conference Call and Webcast for Second Quarter 2023 Financial Results
-
Standard BioTools to Participate in Upcoming Investor Conferences
-
Standard BioTools to Present at the Jefferies Healthcare Conference
-
Standard BioTools Announces NGS Library Preparation as an Upgrade on the X9 High-Throughput Genomics System
-
Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Standard BioTools Reports First Quarter 2023 Financial Results
-
Standard BioTools Announces Conference Call and Webcast for First Quarter 2023 Financial Results
-
Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Labrador Gold Intersects 5.22g/t Au Over 2.8M Including 22.02g/t Over 0.4M
-
Standard BioTools introduces the Hyperion XTi Imaging System, breaks barriers to power significant advancement in spatial biology
-
Labrador Gold Announces Results of Annual General Meeting of Shareholders
-
Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Standard BioTools (LAB) Appoints Fenel Eloi to its Board
-
Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors
-
Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
-
Labrador Gold Intersects 2.32 g/t Au Over 18.6 Metres at Big Vein
-
Standard BioTools to Present at 43rd Annual Cowen Health Care Conference
-
Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Standard BioTools Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Business Outlook
-
Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results
-
Labrador Gold Announces High-Grade Gold and Copper Assays From Hopedale Project Including 21.59 g/t Au From TD500 and 10.2% Cu From Kaapak
-
Labrador Gold Intersects 20.88 g/t Au Over 5 Metres at Big Vein, Kingsway Project
-
Standard BioTools (LAB) Provides Preliminary Fourth Quarter 2022 Revenue and Business Update
-
Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update
-
Standard BioTools Announces Appointment of Betsy Jensen as Chief Human Resources Officer
-
Labrador Gold Reviews Successful Year of Discovery at Kingsway

